ImmunoCellular Therapeutics (IMUC) Reports Q3 Loss of $0.40
Tweet
Share
E-mailGet Alerts IMUC Hot Sheet
Join SI Premium – FREE
ImmunoCellular Therapeutics (NYSE: IMUC) reported Q3 EPS of ($0.40), versus ($1.58) reported last year.
For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Bassett Furniture Industries (BSET) Tops Q2 EPS by 1c, Misses on Revenue
- Netflix gains over 3% as report refutes NBCUniversal acquisition speculation
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
